As observed earlier, one company initially highlighted a focus on therapeutic illness spots but reprioritized vaccines, quite possibly a result of the recognition from the reduced degree of antigen in fact made by the mRNA coupled Together with the low quantities of protein necessary for vaccines because of the amplification with the immune system,